Preventing drug-induced neutropenia involves careful monitoring and dosage adjustments under medical supervision when using known myelosuppressive agents. For those working in environments with potential exposure to hazardous chemicals, implementing proper safety measures, such as personal protective equipment and regular health check-ups, is essential to minimize risks.
